Summary
Introduction
The global bulk drugs market, worth an estimated US$77.33 billion in 2005, grew at a compounded annual growth rate (CAGR) of 9.2% in the last five years. The contract manufacturing of bulk drugs and prescription drugs touched an estimated US$28.97 billion in 2005, and is expected to rise to US$43.34 billion at a CAGR of 10.6% by the end of 2009.
Key Findings & Highlights
Bulk drug industry is undergoing radical change - The thinning research pipelines, the growing pricing pressures and increasing importance of generics are leading to far-reaching changes in the bulk drug industry.
The worldwide production of bulk drugs - active substances in drugs that perform the desired therapeutic actions, totalled US$77.33 billion in 2005- and expected to touch US$84.4 billion in 2006.
The three segments - Branded Prescription Drugs, Over-the-Counter Drugs and Generic Prescription Drugs-account for a majority of global bulk drug consumption.
Reasons to Purchase
Gain a thorough understanding - of new product opportunities of non captive API manufacturers, industry estimates about the drugs which will go off-patent by 2010.
Estimates the production of bulk drugs industry and growth of the production volume over the last five years.
Reveals the top 10 bulk drugs as per the therapeutic class also about their share onto the global bulk drug industry. Also about the Cholesterol & Triglyceride Reducers drugs accounted for bulk drug Consumption
|
